Neutrophil-to-Lymphocyte Ratio Is a Useful Marker for Predicting Histological Types of Early Gastric Cancer.

endoscopic submucosal dissection (ESD) gastric cancer neutrophil-to-lymphocyte ratio (NLR) platelet-to-lymphocyte ratio (PLR)

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
16 Feb 2021
Historique:
received: 29 01 2021
revised: 11 02 2021
accepted: 15 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 7 3 2021
Statut: epublish

Résumé

The indications for endoscopic submucosal dissection (ESD) for gastric cancer are based on preoperative histological assessment; however, examination of tissue biopsy is not always reliable as only a limited portion of the lesion can be obtained. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are markers of inflammatory response and are potentially associated with the grade of malignancy in gastric cancer. We aimed to investigate the association between NLR and PLR and the histology of gastric cancer. This study included 218 patients who underwent ESD for gastric cancer. The relationship between NLR/PLR and histological diagnosis was investigated. Patients with adenocarcinomas showed significantly higher NLR and PLR than those with adenomas ( This study suggests that NLR could be a useful marker for assessing early gastric cancer.

Sections du résumé

BACKGROUND BACKGROUND
The indications for endoscopic submucosal dissection (ESD) for gastric cancer are based on preoperative histological assessment; however, examination of tissue biopsy is not always reliable as only a limited portion of the lesion can be obtained. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are markers of inflammatory response and are potentially associated with the grade of malignancy in gastric cancer. We aimed to investigate the association between NLR and PLR and the histology of gastric cancer.
METHODS METHODS
This study included 218 patients who underwent ESD for gastric cancer. The relationship between NLR/PLR and histological diagnosis was investigated.
RESULTS RESULTS
Patients with adenocarcinomas showed significantly higher NLR and PLR than those with adenomas (
CONCLUSION CONCLUSIONS
This study suggests that NLR could be a useful marker for assessing early gastric cancer.

Identifiants

pubmed: 33669317
pii: jcm10040791
doi: 10.3390/jcm10040791
pmc: PMC7920243
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

PLoS One. 2014 Sep 19;9(9):e106914
pubmed: 25238252
Arthritis Res Ther. 2004;6(4):178-80
pubmed: 15225363
J Clin Med. 2020 Apr 15;9(4):
pubmed: 32326552
Biomarkers. 2014 Sep;19(6):444-51
pubmed: 24910346
Dig Endosc. 2018 Sep;30(5):624-632
pubmed: 29570860
ESMO Open. 2016 Mar 7;1(2):e000038
pubmed: 27843594
J Immunol Res. 2020 Mar 7;2020:9146042
pubmed: 32211444
J Clin Lab Anal. 2014 May;28(3):219-23
pubmed: 24478129
PLoS One. 2015 May 07;10(5):e0126496
pubmed: 25950176
J Transl Med. 2015 Feb 18;13:66
pubmed: 25885254
Rheumatol Int. 2018 Oct;38(10):1865-1871
pubmed: 30088046
Anticancer Res. 2016 Dec;36(12):6557-6562
pubmed: 27919983
Lancet Oncol. 2014 Oct;15(11):e493-503
pubmed: 25281468
BMC Cancer. 2013 Jul 22;13:350
pubmed: 23876227
Dig Dis Sci. 2004 Mar;49(3):417-24
pubmed: 15139491
Gastric Cancer. 2021 Jan;24(1):1-21
pubmed: 32060757
JAMA Oncol. 2015 Jul;1(4):505-27
pubmed: 26181261
Br J Cancer. 2014 Mar 18;110(6):1409-12
pubmed: 24548867
Radiother Oncol. 2016 Feb;118(2):330-4
pubmed: 26653356
Immunity. 2004 Aug;21(2):137-48
pubmed: 15308095
Biochim Biophys Acta. 2016 Mar;1863(3):379-381
pubmed: 26721622
Oncol Lett. 2016 Feb;11(2):1537-1544
pubmed: 26893776
World J Surg. 2010 Oct;34(10):2399-400
pubmed: 20602100
Cancer Manag Res. 2017 Dec 14;9:849-867
pubmed: 29276407
Ren Fail. 2017 Nov;39(1):273-276
pubmed: 27919192
Exp Ther Med. 2015 Apr;9(4):1209-1214
pubmed: 25780411

Auteurs

Sho Yasui (S)

Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Tottori 683-8504, Japan.

Tomoaki Takata (T)

Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Tottori 683-8504, Japan.

Yu Kamitani (Y)

Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Tottori 683-8504, Japan.

Yukari Mae (Y)

Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Tottori 683-8504, Japan.

Hiroki Kurumi (H)

Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Tottori 683-8504, Japan.

Yuichiro Ikebuchi (Y)

Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Tottori 683-8504, Japan.

Akira Yoshida (A)

Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Tottori 683-8504, Japan.

Koichiro Kawaguchi (K)

Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Tottori 683-8504, Japan.

Kazuo Yashima (K)

Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Tottori 683-8504, Japan.

Hajime Isomoto (H)

Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Tottori 683-8504, Japan.

Classifications MeSH